首页 > 最新文献

Endoscopy International Open最新文献

英文 中文
A novel polysaccharide hemostatic agent in prevention of post-procedural bleeding following large colonic polyp resection. 一种新型多糖止血剂预防大结肠息肉切除术后出血。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-09 eCollection Date: 2026-01-01 DOI: 10.1055/a-2794-0465
Francesco Auriemma, Gianluca Franchellucci, Gianluca Andrisani, Francesco Di Matteo, Luca De Luca, Diletta De Deo, Federica Calabrese, Matteo Fiacca, Francesco Minnini, Danilo Paduano, Carmine Gentile, Paola Petrillo, Daryl Ramai, Antonio Facciorusso, Alessandro Repici, Benedetto Mangiavillano

Background and study aims: Preventing post-procedural bleeding (PPB) after endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) is crucial for minimizing post-endoscopic complications. We aimed to evaluate the rate of PPB in large colorectal lesions removed via EMR or ESD, followed by application of a resorbable plant-based hemostatic powder (HaemoCer PLUS).

Patients and methods: This prospective pilot study was conducted at three tertiary care centers from November 2021 to February 2024. HaemoCer PLUS was applied at the end of the procedure and spread over the post-resection surface. No endoscopic clips were used after resection.

Results: The study included 50 patients with a mean lesion diameter of 52.28 mm (standard deviation 18.29 mm). Fifty-six percent of the polyps were in the rectum and 86% were classified as adenomas. ESD was used to remove 20 lesions, hybrid ESD for eight, Hot-EMR for 17, and cold-EMR for five. All patients received HaemoCer PLUS application for PPB prevention. Delayed bleeding was observed in 6% of cases, including one case of ESD and two cases of hot-snare resection. PPB occurred 24 hours after the procedure and no bleeding cases were reported more than 30 days post-endoscopy. Univariate analysis showed no statistically significant associations between post-procedural bleeding and lesion size, patient age, or endoscopic resection technique.

Conclusions: Use of a novel resorbable plant-based hemostatic powder could be a beneficial method for reducing delayed bleeding complications, particularly in high-risk groups characterized by specific lesions and patient factors.

背景与研究目的:预防内镜下粘膜切除术(EMR)和内镜下粘膜剥离(ESD)术后出血(PPB)是减少内镜后并发症的关键。我们的目的是评估通过EMR或ESD切除的大肠癌病变中PPB的发生率,然后应用可吸收的植物性止血粉(HaemoCer PLUS)。患者和方法:本前瞻性试点研究于2021年11月至2024年2月在三家三级医疗中心进行。在手术结束时应用HaemoCer PLUS,并在切除后表面扩散。切除后未使用内镜夹。结果:纳入50例患者,平均病变直径为52.28 mm(标准差为18.29 mm)。56%的息肉发生在直肠,86%被归类为腺瘤。ESD切除病灶20例,混合ESD切除病灶8例,Hot-EMR切除病灶17例,cold-EMR切除病灶5例。所有患者均接受了HaemoCer PLUS预防PPB的应用。迟发性出血占6%,包括1例ESD和2例热陷切除术。PPB发生在手术后24小时,内镜检查后30天没有出血病例报告。单因素分析显示,术后出血与病变大小、患者年龄或内镜切除技术之间无统计学意义的关联。结论:使用一种新型可吸收的植物性止血粉可能是减少延迟性出血并发症的有益方法,特别是在具有特定病变和患者因素的高危人群中。
{"title":"A novel polysaccharide hemostatic agent in prevention of post-procedural bleeding following large colonic polyp resection.","authors":"Francesco Auriemma, Gianluca Franchellucci, Gianluca Andrisani, Francesco Di Matteo, Luca De Luca, Diletta De Deo, Federica Calabrese, Matteo Fiacca, Francesco Minnini, Danilo Paduano, Carmine Gentile, Paola Petrillo, Daryl Ramai, Antonio Facciorusso, Alessandro Repici, Benedetto Mangiavillano","doi":"10.1055/a-2794-0465","DOIUrl":"https://doi.org/10.1055/a-2794-0465","url":null,"abstract":"<p><strong>Background and study aims: </strong>Preventing post-procedural bleeding (PPB) after endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) is crucial for minimizing post-endoscopic complications. We aimed to evaluate the rate of PPB in large colorectal lesions removed via EMR or ESD, followed by application of a resorbable plant-based hemostatic powder (HaemoCer PLUS).</p><p><strong>Patients and methods: </strong>This prospective pilot study was conducted at three tertiary care centers from November 2021 to February 2024. HaemoCer PLUS was applied at the end of the procedure and spread over the post-resection surface. No endoscopic clips were used after resection.</p><p><strong>Results: </strong>The study included 50 patients with a mean lesion diameter of 52.28 mm (standard deviation 18.29 mm). Fifty-six percent of the polyps were in the rectum and 86% were classified as adenomas. ESD was used to remove 20 lesions, hybrid ESD for eight, Hot-EMR for 17, and cold-EMR for five. All patients received HaemoCer PLUS application for PPB prevention. Delayed bleeding was observed in 6% of cases, including one case of ESD and two cases of hot-snare resection. PPB occurred 24 hours after the procedure and no bleeding cases were reported more than 30 days post-endoscopy. Univariate analysis showed no statistically significant associations between post-procedural bleeding and lesion size, patient age, or endoscopic resection technique.</p><p><strong>Conclusions: </strong>Use of a novel resorbable plant-based hemostatic powder could be a beneficial method for reducing delayed bleeding complications, particularly in high-risk groups characterized by specific lesions and patient factors.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27940465"},"PeriodicalIF":2.3,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12951033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147347503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-dimensional ERCP with cone-beam computed tomography: Novel approach to managing complex biliary strictures. 三维ERCP与锥束计算机断层扫描:处理复杂胆道狭窄的新方法。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-09 eCollection Date: 2026-01-01 DOI: 10.1055/a-2796-5509
Kanika Garg, Gaurav Kakked, Thomas Wang, Christopher G Chapman, Ajaypal Singh, Irving Waxman, Neal A Mehta

Background and study aims: Complex perihilar and intrahepatic biliary strictures present significant therapeutic challenges during endoscopic retrograde cholangiopancreatography (ERCP), with traditional two-dimensional fluoroscopy limiting spatial visualization. This prospective cohort study evaluated feasibility and clinical utility of novel three-dimensional (3D) fluoroscopic imaging utilizing cone beam computed tomography (CBCT) in ERCP for managing complex biliary strictures.

Patients and methods: Twenty consecutive patients with complex biliary strictures underwent ERCP with CBCT at a single tertiary center between September 2023 and December 2024. All patients had previously failed selective cannulation attempts. Using a specialized fluoroscopic system, 360-degree rotational imaging was performed. Primary outcomes included technical success (selective cannulation rate) and clinical success (successful stenting without percutaneous drainage).

Results: Stricture etiology was malignant in 60% and benign in 40%. CBCT achieved selective cannulation in 100% of cases and clinical success in 90%. Two patients required percutaneous drainage. 3D reconstruction influenced surgical planning in 10% of cases. Standard ERCP resulted in median entrance skin dose (ESD) of 156.0 mGy (range 67.3-273.0) and dose area product (DAP) of 44.4 (range 21.1-94.0] . The 3D reconstruction from CBCT contributed an additional median ESD of 174.0 mGy (range 137.0-240.0) and DAP of 53.1 Gy·cm 2 (range 41.8-73.8).

Conclusions: ERCP with CBCT is technically feasible with high selective cannulation rates in complex biliary strictures. Although the technique requires additional radiation exposure, it may provide value in cases with difficult selective cannulation and surgical mapping for malignancies. Further studies are needed to define optimal patient selection and evaluate long-term outcomes.

背景和研究目的:复杂的肝门周围和肝内胆道狭窄在内镜逆行胆管胰胆管造影(ERCP)中是一个重大的治疗挑战,传统的二维透视限制了空间可视化。本前瞻性队列研究评估了利用锥形束计算机断层扫描(CBCT)在ERCP中治疗复杂胆道狭窄的新型三维(3D)透视成像的可行性和临床应用。患者和方法:2023年9月至2024年12月,连续20例复杂胆道狭窄患者在单一三级中心接受ERCP + CBCT。所有患者之前都曾尝试选择性插管失败。使用专门的透视系统,进行360度旋转成像。主要结果包括技术成功(选择性插管率)和临床成功(支架置入术成功且无经皮引流)。结果:狭窄病因恶性占60%,良性占40%。CBCT的选择性插管率为100%,临床成功率为90%。2例患者需要经皮引流。10%的病例三维重建影响手术计划。标准ERCP导致皮肤中位入口剂量(ESD)为156.0 mGy(范围67.3-273.0),剂量面积积(DAP)为44.4(范围21.1-94.0)。CBCT三维重建的平均ESD为174.0 mGy(范围137.0-240.0),DAP为53.1 Gy·cm2(范围41.8-73.8)。结论:ERCP结合CBCT治疗复杂胆道狭窄在技术上是可行的,有较高的选择性插管率。虽然该技术需要额外的辐射暴露,但它可能在难以选择插管和恶性肿瘤手术定位的情况下提供价值。需要进一步的研究来确定最佳的患者选择和评估长期结果。
{"title":"Three-dimensional ERCP with cone-beam computed tomography: Novel approach to managing complex biliary strictures.","authors":"Kanika Garg, Gaurav Kakked, Thomas Wang, Christopher G Chapman, Ajaypal Singh, Irving Waxman, Neal A Mehta","doi":"10.1055/a-2796-5509","DOIUrl":"https://doi.org/10.1055/a-2796-5509","url":null,"abstract":"<p><strong>Background and study aims: </strong>Complex perihilar and intrahepatic biliary strictures present significant therapeutic challenges during endoscopic retrograde cholangiopancreatography (ERCP), with traditional two-dimensional fluoroscopy limiting spatial visualization. This prospective cohort study evaluated feasibility and clinical utility of novel three-dimensional (3D) fluoroscopic imaging utilizing cone beam computed tomography (CBCT) in ERCP for managing complex biliary strictures.</p><p><strong>Patients and methods: </strong>Twenty consecutive patients with complex biliary strictures underwent ERCP with CBCT at a single tertiary center between September 2023 and December 2024. All patients had previously failed selective cannulation attempts. Using a specialized fluoroscopic system, 360-degree rotational imaging was performed. Primary outcomes included technical success (selective cannulation rate) and clinical success (successful stenting without percutaneous drainage).</p><p><strong>Results: </strong>Stricture etiology was malignant in 60% and benign in 40%. CBCT achieved selective cannulation in 100% of cases and clinical success in 90%. Two patients required percutaneous drainage. 3D reconstruction influenced surgical planning in 10% of cases. Standard ERCP resulted in median entrance skin dose (ESD) of 156.0 mGy (range 67.3-273.0) and dose area product (DAP) of 44.4 (range 21.1-94.0] . The 3D reconstruction from CBCT contributed an additional median ESD of 174.0 mGy (range 137.0-240.0) and DAP of 53.1 Gy·cm <sup>2</sup> (range 41.8-73.8).</p><p><strong>Conclusions: </strong>ERCP with CBCT is technically feasible with high selective cannulation rates in complex biliary strictures. Although the technique requires additional radiation exposure, it may provide value in cases with difficult selective cannulation and surgical mapping for malignancies. Further studies are needed to define optimal patient selection and evaluate long-term outcomes.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27965509"},"PeriodicalIF":2.3,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12951041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147347893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Second lesions located within the same belt-like region along the stomach's short axis as primary lesions: Boundary equal lesion trends. 第二病变位于与原发性病变相同的沿胃短轴的带状区域内:边界相等病变趋势。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-05 eCollection Date: 2026-01-01 DOI: 10.1055/a-2789-1092
Toshifumi Iida, Yoshiaki Kimoto, Etsuko Yamabe, Miuzen Kanamori, Susumu Banjoya, Tomoya Kimura, Koichi Furuta, Shinya Nagae, Hiroshi Yamazaki, Nao Takeuchi, Shunya Takayanagi, Takafumi Konishi, Yuki Kano, Kohei Ono, Ryoju Negishi, Yohei Minato, Hideyuki Chiba, Ken Ohata

Background and study aims: Gastric adenoma and cancer are common in Asia, with early detection critical for prognosis. Synchronous multiple early gastric cancers (SMEGCs) occur in 6% to 14% of cases, but their clinicopathological characteristics remain unclear. This study analyzed synchronous multiple gastric neoplasms treated by endoscopic resection or surgery to aid early detection.

Patients and methods: Among 2,991 cases of early gastric cancer or adenoma diagnosed at our institution, 173 patients with 346 synchronous lesions (January 2016-March 2024) were analyzed. All lesions were mucosal or submucosal. Lesions were categorized as "1st" (larger) and "2nd" (smaller), and clinicopathological characteristics were compared using Chi-square and Fisher's exact tests with Cramér's V.

Results: Patients had a mean age of 73.2 years; 72.8% were male. Most lesions were in the lower/middle stomach, differentiated (92.2%), depressed (52.9%), and brownish on narrow-band imaging (65.3%). Mean tumor diameter was 13.4 mm. Although 1st lesions were larger, other features showed high concordance (≥ 0.25 Cramér's V) in location, morphology, histology, invasion depth, and coloration. Survival was 94.8% (nine unrelated deaths).

Conclusions: Synchronous multiple gastric neoplasms tend to have similar endoscopic and histopathologic features and often occur within the same belt-like region along the short axis of the stomach. This pattern was named boundary equal lesions trends (BELT). When detecting one lesion, considering BELT is essential.

背景和研究目的:胃腺瘤和胃癌在亚洲很常见,早期发现对预后至关重要。同步多发性早期胃癌(SMEGCs)发生率为6%至14%,但其临床病理特征尚不清楚。本研究分析了通过内镜切除或手术治疗的同步多发性胃肿瘤,以帮助早期发现。患者和方法:分析我院诊断的2991例早期胃癌或腺瘤患者中,2016年1月- 2024年3月同步病变173例346例。所有病变均为粘膜或粘膜下病变。病变分为“1”级(较大)和“2”级(较小),临床病理特征采用卡方检验和Fisher精确检验与cramsamrs v进行比较。结果:患者平均年龄73.2岁;72.8%为男性。大多数病变位于胃的下/中部,呈分化(92.2%),凹陷(52.9%),窄频带呈褐色(65.3%)。平均肿瘤直径13.4 mm。虽然第一个病变较大,但其他特征在位置、形态、组织学、浸润深度和颜色上表现出高度的一致性(≥0.25 cram rs V)。生存率为94.8%(9例无关死亡)。结论:同步多发胃肿瘤往往具有相似的内镜和组织病理学特征,常发生在胃短轴的同一带状区域。这种模式被命名为边界等损趋势(BELT)。当发现一个病变时,考虑BELT是必要的。
{"title":"Second lesions located within the same belt-like region along the stomach's short axis as primary lesions: Boundary equal lesion trends.","authors":"Toshifumi Iida, Yoshiaki Kimoto, Etsuko Yamabe, Miuzen Kanamori, Susumu Banjoya, Tomoya Kimura, Koichi Furuta, Shinya Nagae, Hiroshi Yamazaki, Nao Takeuchi, Shunya Takayanagi, Takafumi Konishi, Yuki Kano, Kohei Ono, Ryoju Negishi, Yohei Minato, Hideyuki Chiba, Ken Ohata","doi":"10.1055/a-2789-1092","DOIUrl":"https://doi.org/10.1055/a-2789-1092","url":null,"abstract":"<p><strong>Background and study aims: </strong>Gastric adenoma and cancer are common in Asia, with early detection critical for prognosis. Synchronous multiple early gastric cancers (SMEGCs) occur in 6% to 14% of cases, but their clinicopathological characteristics remain unclear. This study analyzed synchronous multiple gastric neoplasms treated by endoscopic resection or surgery to aid early detection.</p><p><strong>Patients and methods: </strong>Among 2,991 cases of early gastric cancer or adenoma diagnosed at our institution, 173 patients with 346 synchronous lesions (January 2016-March 2024) were analyzed. All lesions were mucosal or submucosal. Lesions were categorized as \"1st\" (larger) and \"2nd\" (smaller), and clinicopathological characteristics were compared using Chi-square and Fisher's exact tests with Cramér's V.</p><p><strong>Results: </strong>Patients had a mean age of 73.2 years; 72.8% were male. Most lesions were in the lower/middle stomach, differentiated (92.2%), depressed (52.9%), and brownish on narrow-band imaging (65.3%). Mean tumor diameter was 13.4 mm. Although 1st lesions were larger, other features showed high concordance (≥ 0.25 Cramér's V) in location, morphology, histology, invasion depth, and coloration. Survival was 94.8% (nine unrelated deaths).</p><p><strong>Conclusions: </strong>Synchronous multiple gastric neoplasms tend to have similar endoscopic and histopathologic features and often occur within the same belt-like region along the short axis of the stomach. This pattern was named boundary equal lesions trends (BELT). When detecting one lesion, considering BELT is essential.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27891092"},"PeriodicalIF":2.3,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12951031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147347905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adenoma detection rates and complications of colonoscopy in patients aged 75 to 79 vs 70 to 74 years: Propensity score-matching study. 75 - 79岁患者与70 - 74岁患者结肠镜检查的腺瘤检出率和并发症:倾向评分匹配研究
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-03 eCollection Date: 2026-01-01 DOI: 10.1055/a-2788-3397
Osamu Toyoshima, Toshihiro Nishizawa, Shuntaro Yoshida, Tomoharu Yamada, Keisuke Mabuchi, Takuma Kaneko, Mari Mizutani, Hirotoshi Ebinuma, Mitsuhiro Fujishiro, Keisuke Hata

Background and study aims: Several guidelines recommend discontinuation of routine surveillance colonoscopy after age 75 years. Because Japan has one of the longest life expectancies, we considered ceasing at age 80 years. We compared patients aged 75 to 79 years with those aged 70 to 74 years, regarding adenoma detection rate (ADR), mean number of adenomas per colonoscopy, and adverse events.

Patients and methods: This propensity score-matching (PSM) study included patients aged 70 to 79 years with a performance status of 0 to 1 who underwent colonoscopies at Toyoshima Endoscopy Clinic between 2017 and 2024. Patients aged 75 to 79 years were matched with those aged 70 to 74 years for baseline characteristics using the propensity score. ADR, mean number of adenomas per colonoscopy, frequency of respiratory depression, hypotension, and delayed post-polypectomy bleeding were compared between the two groups.

Results: During the study period, 3415 patients were included. The ADR in patients aged 75 to 79 years was higher than that in patients aged 70 to 74 years (66.5% vs 62.2%, P = 0.021). Mean number of adenomas per colonoscopy in patients aged 75 to 79 years was higher than that in patients aged 70 to 74 years (1.54 vs 1.38, P = 0.014). The two groups did not show significant differences in respiratory depression (2.6% vs 2.3%), hypotension (0.8% vs 1.0%) or delayed post-polypectomy bleeding (0.2% vs 0.4%).

Conclusions: Colonoscopies for patients aged 75 to 79 are safe and effective in Japan.

背景和研究目的:一些指南建议在75岁后停止常规结肠镜检查。因为日本是预期寿命最长的国家之一,我们考虑在80岁时停止。我们比较了75 - 79岁患者和70 - 74岁患者的腺瘤检出率(ADR)、每次结肠镜检查腺瘤的平均数量和不良事件。患者和方法:这项倾向评分匹配(PSM)研究纳入了年龄在70至79岁、表现状态为0至1的患者,这些患者于2017年至2024年在丰田岛内窥镜诊所接受了结肠镜检查。使用倾向评分将75至79岁的患者与70至74岁的患者进行基线特征匹配。比较两组患者的不良反应、每次结肠镜检查腺瘤的平均数量、呼吸抑制、低血压和息肉切除后延迟出血的频率。结果:研究期间共纳入3415例患者。75 ~ 79岁患者不良反应发生率高于70 ~ 74岁患者(66.5% vs 62.2%, P = 0.021)。75 ~ 79岁患者每次结肠镜检查平均腺瘤数高于70 ~ 74岁患者(1.54 vs 1.38, P = 0.014)。两组在呼吸抑制(2.6% vs 2.3%)、低血压(0.8% vs 1.0%)或息肉切除后延迟出血(0.2% vs 0.4%)方面无显著差异。结论:在日本,75 - 79岁患者的结肠镜检查是安全有效的。
{"title":"Adenoma detection rates and complications of colonoscopy in patients aged 75 to 79 vs 70 to 74 years: Propensity score-matching study.","authors":"Osamu Toyoshima, Toshihiro Nishizawa, Shuntaro Yoshida, Tomoharu Yamada, Keisuke Mabuchi, Takuma Kaneko, Mari Mizutani, Hirotoshi Ebinuma, Mitsuhiro Fujishiro, Keisuke Hata","doi":"10.1055/a-2788-3397","DOIUrl":"https://doi.org/10.1055/a-2788-3397","url":null,"abstract":"<p><strong>Background and study aims: </strong>Several guidelines recommend discontinuation of routine surveillance colonoscopy after age 75 years. Because Japan has one of the longest life expectancies, we considered ceasing at age 80 years. We compared patients aged 75 to 79 years with those aged 70 to 74 years, regarding adenoma detection rate (ADR), mean number of adenomas per colonoscopy, and adverse events.</p><p><strong>Patients and methods: </strong>This propensity score-matching (PSM) study included patients aged 70 to 79 years with a performance status of 0 to 1 who underwent colonoscopies at Toyoshima Endoscopy Clinic between 2017 and 2024. Patients aged 75 to 79 years were matched with those aged 70 to 74 years for baseline characteristics using the propensity score. ADR, mean number of adenomas per colonoscopy, frequency of respiratory depression, hypotension, and delayed post-polypectomy bleeding were compared between the two groups.</p><p><strong>Results: </strong>During the study period, 3415 patients were included. The ADR in patients aged 75 to 79 years was higher than that in patients aged 70 to 74 years (66.5% vs 62.2%, <i>P</i> = 0.021). Mean number of adenomas per colonoscopy in patients aged 75 to 79 years was higher than that in patients aged 70 to 74 years (1.54 vs 1.38, <i>P</i> = 0.014). The two groups did not show significant differences in respiratory depression (2.6% vs 2.3%), hypotension (0.8% vs 1.0%) or delayed post-polypectomy bleeding (0.2% vs 0.4%).</p><p><strong>Conclusions: </strong>Colonoscopies for patients aged 75 to 79 are safe and effective in Japan.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27883397"},"PeriodicalIF":2.3,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12951028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147347670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and acceptability of bowel preparation strategies for inflammatory bowel disease colonoscopy: Systematic review and meta-analysis. 炎症性肠病结肠镜检查的肠准备策略的有效性和可接受性:系统回顾和荟萃分析。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-02 eCollection Date: 2026-01-01 DOI: 10.1055/a-2778-9563
Gaurav B Nigam, Morris Gordon, Vassiliki Sinopoulou, Anukriti Tomar, Shahida Din, Margaret Vance, Ana Wilson, James E East

Background and study aims: Patients with inflammatory bowel disease (IBD) frequently undergo colonoscopy, each requiring bowel preparation. European Society of Gastrointestinal Endoscopy (ESGE) 2019 guidelines recommended high- or low-volume polyethylene glycol (PEG)-based bowel prep for IBD patients; however other non-PEG-based preparations (sulphate and picosulphate-based) have now been studied in IBD.

Methods: We searched CENTRAL, ClinicalTrials.gov, Embase, MEDLINE, and the World Health Organization International Clinical Trials Registry Platform for randomized controlled trials (RCTs) up to December 2024. Primary outcome was bowel prep success; secondary outcomes included tolerability, acceptability, cecal intubation rates (CIR) and safety. Pooled estimates used risk ratio (RR) and GRADE to assess evidence certainty.

Results: Ten RCTs (1479 IBD patients) were included. There was no difference in prep success (relative risk [RR] 0.98, 95% confidence interval [CI] 0.88-1.09; I 2 = 33%, 2 RCTs; moderate certainty evidence) between 2 L vs. 4 L PEG, but higher acceptability for 2 L (RR 0.69, 95% CI 0.59-0.80; I 2 = 18%, 2 RCTs; high certainty evidence). Low-volume non-PEG vs. PEG are probably similar for prep success (RR 0.96, 95% CI 0.90-1.01; I 2 = 6%,3 RCTs; moderate certainty evidence). The evidence on tolerability and acceptability was very uncertain. Subgroup analysis revealed comparable effectiveness of picosulphate-based (RR 0.89, 95% CI 0.78-1.01; I 2 = 0%,1 RCT) and sulphate-based preps (RR 0.98, 95% CI 0.91-1.05; I 2 = 28%, 2 RCTs) compared with low-volume PEG. Safety data were inconsistently reported.

Conclusions: High-certainty evidence supports low-volume PEG as comparably successful to high-volume PEG, with higher acceptability. Moderate-certainty evidence indicates similar success between non-PEG and PEG-based preps. Both low-volume PEG and non-PEG-based preps are supported for use in IBD, broadening options beyond current ESGE guidelines.

背景和研究目的:炎症性肠病(IBD)患者经常接受结肠镜检查,每个患者都需要肠道准备。欧洲胃肠内镜学会(ESGE) 2019指南推荐IBD患者采用高容量或低容量聚乙二醇(PEG)为基础的肠道准备;然而,其他非聚乙二醇基制剂(硫酸盐和微硫酸盐基)现在已经在IBD中进行了研究。方法:我们检索了截至2024年12月的CENTRAL、ClinicalTrials.gov、Embase、MEDLINE和世界卫生组织国际临床试验注册平台的随机对照试验(rct)。主要结局为肠道准备成功;次要结局包括耐受性、可接受性、盲肠插管率(CIR)和安全性。合并估计使用风险比(RR)和GRADE来评估证据的确定性。结果:纳入10项rct(1479例IBD患者)。2升与4升PEG的准备成功率无差异(相对危险度[RR] 0.98, 95%可信区间[CI] 0.88-1.09; I 2 = 33%, 2个随机对照试验;中等确定性证据),但2升PEG的可接受性较高(RR 0.69, 95% CI 0.59-0.80; I 2 = 18%, 2个随机对照试验;高确定性证据)。小容量非PEG与PEG在准备成功率方面可能相似(RR 0.96, 95% CI 0.90-1.01; I 2 = 6%,3个rct;中等确定性证据)。关于耐受性和可接受性的证据非常不确定。亚组分析显示,与小体积PEG相比,以picosulfate为基础的制剂(RR 0.89, 95% CI 0.78-1.01; I 2 = 0%,1项RCT)和以硫酸盐为基础的制剂(RR 0.98, 95% CI 0.91-1.05; I 2 = 28%, 2项RCT)的有效性相当。安全数据报告不一致。结论:高确定性证据支持小体积PEG比大体积PEG更成功,具有更高的可接受性。中等确定性的证据表明,非peg和peg基制备之间的成功相似。支持在IBD中使用小体积PEG和非PEG基制剂,拓宽了当前ESGE指南之外的选择。
{"title":"Efficacy and acceptability of bowel preparation strategies for inflammatory bowel disease colonoscopy: Systematic review and meta-analysis.","authors":"Gaurav B Nigam, Morris Gordon, Vassiliki Sinopoulou, Anukriti Tomar, Shahida Din, Margaret Vance, Ana Wilson, James E East","doi":"10.1055/a-2778-9563","DOIUrl":"https://doi.org/10.1055/a-2778-9563","url":null,"abstract":"<p><strong>Background and study aims: </strong>Patients with inflammatory bowel disease (IBD) frequently undergo colonoscopy, each requiring bowel preparation. European Society of Gastrointestinal Endoscopy (ESGE) 2019 guidelines recommended high- or low-volume polyethylene glycol (PEG)-based bowel prep for IBD patients; however other non-PEG-based preparations (sulphate and picosulphate-based) have now been studied in IBD.</p><p><strong>Methods: </strong>We searched CENTRAL, ClinicalTrials.gov, Embase, MEDLINE, and the World Health Organization International Clinical Trials Registry Platform for randomized controlled trials (RCTs) up to December 2024. Primary outcome was bowel prep success; secondary outcomes included tolerability, acceptability, cecal intubation rates (CIR) and safety. Pooled estimates used risk ratio (RR) and GRADE to assess evidence certainty.</p><p><strong>Results: </strong>Ten RCTs (1479 IBD patients) were included. There was no difference in prep success (relative risk [RR] 0.98, 95% confidence interval [CI] 0.88-1.09; I <sup>2</sup> = 33%, 2 RCTs; moderate certainty evidence) between 2 L vs. 4 L PEG, but higher acceptability for 2 L (RR 0.69, 95% CI 0.59-0.80; I <sup>2</sup> = 18%, 2 RCTs; high certainty evidence). Low-volume non-PEG vs. PEG are probably similar for prep success (RR 0.96, 95% CI 0.90-1.01; I <sup>2</sup> = 6%,3 RCTs; moderate certainty evidence). The evidence on tolerability and acceptability was very uncertain. Subgroup analysis revealed comparable effectiveness of picosulphate-based (RR 0.89, 95% CI 0.78-1.01; I <sup>2</sup> = 0%,1 RCT) and sulphate-based preps (RR 0.98, 95% CI 0.91-1.05; I <sup>2</sup> = 28%, 2 RCTs) compared with low-volume PEG. Safety data were inconsistently reported.</p><p><strong>Conclusions: </strong>High-certainty evidence supports low-volume PEG as comparably successful to high-volume PEG, with higher acceptability. Moderate-certainty evidence indicates similar success between non-PEG and PEG-based preps. Both low-volume PEG and non-PEG-based preps are supported for use in IBD, broadening options beyond current ESGE guidelines.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27789563"},"PeriodicalIF":2.3,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12951038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147347618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic ultrasonography-guided gastroenterostomy for malignant gastric outlet obstruction: Comparison between gastric and duodenal obstruction. 超声内镜引导下胃肠造口术治疗恶性胃出口梗阻:胃梗阻与十二指肠梗阻的比较。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-02 eCollection Date: 2026-01-01 DOI: 10.1055/a-2760-4544
Yorick L van de Pavert, Maronne I D Pheifer, Louise W H van Leeuwen, Rina Bijlsma, Marco Bruno, Hendrik M van Dullemen, Paul Fockens, Akin Inderson, Willem J Lammers, Niels G Venneman, Rogier P Voermans, Roy L J van Wanrooij, Thomas R de Wijkerslooth, Leon M G Moons, Frank P Vleggaar

Background and study aims: It is currently unclear whether obstruction location affects clinical and procedure outcomes after endoscopic ultrasonography-guided gastroenterostomy (EUS-GE) with a lumen-apposing metal stent (LAMS) in patients with malignant gastric outlet obstruction (GOO). Therefore, we compared clinical outcomes of EUS-GE for malignant GOO located in the stomach with obstruction located in the duodenum.

Patients and methods: In this nationwide, multicenter, retrospective study, we included consecutive patients who underwent EUS-GE as palliative treatment for malignant GOO. Main outcomes were clinical success, serious adverse events (SAEs) recurrence of obstructive symptoms, and LAMS dysfunction.

Results: Between 2018 and 2023, 298 patients underwent EUS-GE. Clinical success was achieved in 73 of 82 patients with a gastric obstruction (94%) and in 174 of 216 patients with a duodenal obstruction (87%). No association was found between location of obstruction and clinical success (odds ratio [OR] 2.62, 95% confidence interval [CI] 0.91 to 7.52, P = 0.073) or SAEs (OR 0.26, 95% CI 0.06 to 1.20, P = 0.083). Recurrent obstructive symptoms occurred more frequently in patients with a gastric obstruction (hazard ratio 1.74, 95% CI 1.09 to 2.77, P = 0.020). LAMS dysfunction did not differ between the groups (7 patients [9%] with a gastric obstruction and 11 patients [5%] with a duodenal obstruction).

Conclusions: In this study, EUS-GE in patients with a gastric obstruction had comparable technical and clinical efficacy and a similar safety profile to EUS-GE for duodenal obstruction. However, gastric obstruction was associated with recurrent symptoms of obstruction unrelated to LAMS dysfunction.

背景与研究目的:对于恶性胃出口梗阻(GOO)患者,超声内镜引导下置入置管金属支架(LAMS)的胃肠道造口术(EUS-GE)后,梗阻位置是否会影响其临床和手术结果,目前尚不清楚。因此,我们比较了EUS-GE对位于胃的恶性粘稠物和位于十二指肠的梗阻的临床结果。患者和方法:在这项全国性、多中心、回顾性研究中,我们纳入了连续接受EUS-GE作为恶性粘稠性粘稠物姑息治疗的患者。主要结局为临床成功、严重不良事件(SAEs)梗阻性症状复发和LAMS功能障碍。结果:2018年至2023年间,298例患者接受了EUS-GE。82例胃梗阻患者中有73例(94%)获得临床成功,216例十二指肠梗阻患者中有174例(87%)获得临床成功。梗阻位置与临床成功(比值比[OR] 2.62, 95%可信区间[CI] 0.91 ~ 7.52, P = 0.073)或sae(比值比[OR] 0.26, 95% CI 0.06 ~ 1.20, P = 0.083)之间无关联。胃梗阻患者出现复发性梗阻症状的频率更高(风险比1.74,95% CI 1.09 ~ 2.77, P = 0.020)。两组间LAMS功能障碍无差异(7例[9%]胃梗阻,11例[5%]十二指肠梗阻)。结论:在本研究中,胃梗阻患者的EUS-GE与十二指肠梗阻患者的EUS-GE具有相当的技术和临床疗效以及相似的安全性。然而,胃梗阻与与LAMS功能障碍无关的梗阻复发症状相关。
{"title":"Endoscopic ultrasonography-guided gastroenterostomy for malignant gastric outlet obstruction: Comparison between gastric and duodenal obstruction.","authors":"Yorick L van de Pavert, Maronne I D Pheifer, Louise W H van Leeuwen, Rina Bijlsma, Marco Bruno, Hendrik M van Dullemen, Paul Fockens, Akin Inderson, Willem J Lammers, Niels G Venneman, Rogier P Voermans, Roy L J van Wanrooij, Thomas R de Wijkerslooth, Leon M G Moons, Frank P Vleggaar","doi":"10.1055/a-2760-4544","DOIUrl":"https://doi.org/10.1055/a-2760-4544","url":null,"abstract":"<p><strong>Background and study aims: </strong>It is currently unclear whether obstruction location affects clinical and procedure outcomes after endoscopic ultrasonography-guided gastroenterostomy (EUS-GE) with a lumen-apposing metal stent (LAMS) in patients with malignant gastric outlet obstruction (GOO). Therefore, we compared clinical outcomes of EUS-GE for malignant GOO located in the stomach with obstruction located in the duodenum.</p><p><strong>Patients and methods: </strong>In this nationwide, multicenter, retrospective study, we included consecutive patients who underwent EUS-GE as palliative treatment for malignant GOO. Main outcomes were clinical success, serious adverse events (SAEs) recurrence of obstructive symptoms, and LAMS dysfunction.</p><p><strong>Results: </strong>Between 2018 and 2023, 298 patients underwent EUS-GE. Clinical success was achieved in 73 of 82 patients with a gastric obstruction (94%) and in 174 of 216 patients with a duodenal obstruction (87%). No association was found between location of obstruction and clinical success (odds ratio [OR] 2.62, 95% confidence interval [CI] 0.91 to 7.52, <i>P</i> = 0.073) or SAEs (OR 0.26, 95% CI 0.06 to 1.20, <i>P</i> = 0.083). Recurrent obstructive symptoms occurred more frequently in patients with a gastric obstruction (hazard ratio 1.74, 95% CI 1.09 to 2.77, <i>P</i> = 0.020). LAMS dysfunction did not differ between the groups (7 patients [9%] with a gastric obstruction and 11 patients [5%] with a duodenal obstruction).</p><p><strong>Conclusions: </strong>In this study, EUS-GE in patients with a gastric obstruction had comparable technical and clinical efficacy and a similar safety profile to EUS-GE for duodenal obstruction. However, gastric obstruction was associated with recurrent symptoms of obstruction unrelated to LAMS dysfunction.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27604544"},"PeriodicalIF":2.3,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12951034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147347812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of a novel sheath designed for mapping biopsy for preoperative malignant hilar biliary obstruction. 一种新型鞘设计用于术前恶性肝门胆道梗阻的穿刺活检。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-30 eCollection Date: 2026-01-01 DOI: 10.1055/a-2787-1325
Hiroki Sakamoto, Hirotoshi Ishiwatari, Masahiro Yamamura, Takuya Doi, Junya Sato, Yuko Kakuda, Tomoko Norose, Nobuyuki Oike, Teiichi Sugiura, Katsuhiko Uesaka

Background and study aims: Mapping biopsy (MB) aids in diagnosing superficial mucosal spread of biliary tract cancer. However, conventional MB is technically challenging, which can reduce the diagnostic yield. This study aimed to assess the usefulness of MB using the newly developed Endosheather (ES) (Piolax, Tokyo, Japan).

Patients and methods: We retrospectively analyzed data from patients who had biliary tract cancer with hilar biliary obstruction and underwent MB. Outcome measures included the overall technical success rate, quality of specimens, impact of MB results on the treatment strategy, and adverse events (AEs), which were compared between the conventional (Conv) group and the ES group.

Results: A total of 91 patients were included. The overall technical success rate was significantly higher in the ES group (92%, 43/47) than in the Conv group (59%, 26/44) ( P < 0.05). The rate of samples containing both biliary epithelium and stromal tissue was significantly higher in the ES group than in the Conv group (77% [67/87] vs. 47% [32/68]; P < 0.05). MB results affected the treatment strategy in one patient (2.3%) in the Conv group and five patients (11%) in the ES group ( P = 0.11). There was no significant difference between the two groups in terms of AEs.

Conclusions: MB using ES significantly improved technical success and specimen quality, providing valuable information for preoperative assessment of patients with biliary tract cancer.

背景与研究目的:定位活检(MB)有助于胆道癌浅表粘膜扩散的诊断。然而,传统的MB在技术上具有挑战性,这可能会降低诊断率。本研究旨在评估使用新开发的Endosheather (ES) (Piolax, Tokyo, Japan)的MB的有效性。患者和方法:我们回顾性分析了胆道癌合并肝门胆道梗阻并行MB的患者的资料。结局指标包括总体技术成功率、标本质量、MB结果对治疗策略的影响和不良事件(ae),并在常规(Conv)组和ES组之间进行比较。结果:共纳入91例患者。ES组总技术成功率(92%,43/47)显著高于Conv组(59%,26/44)(P < 0.05)。ES组标本中胆道上皮和间质组织的比例明显高于Conv组(77% [67/87]vs. 47% [32/68]; P < 0.05)。MB结果影响Conv组1例(2.3%)患者和ES组5例(11%)患者的治疗策略(P = 0.11)。两组在ae方面无显著差异。结论:使用ES的MB显著提高了技术成功率和标本质量,为胆道癌患者的术前评估提供了有价值的信息。
{"title":"Utility of a novel sheath designed for mapping biopsy for preoperative malignant hilar biliary obstruction.","authors":"Hiroki Sakamoto, Hirotoshi Ishiwatari, Masahiro Yamamura, Takuya Doi, Junya Sato, Yuko Kakuda, Tomoko Norose, Nobuyuki Oike, Teiichi Sugiura, Katsuhiko Uesaka","doi":"10.1055/a-2787-1325","DOIUrl":"https://doi.org/10.1055/a-2787-1325","url":null,"abstract":"<p><strong>Background and study aims: </strong>Mapping biopsy (MB) aids in diagnosing superficial mucosal spread of biliary tract cancer. However, conventional MB is technically challenging, which can reduce the diagnostic yield. This study aimed to assess the usefulness of MB using the newly developed Endosheather (ES) (Piolax, Tokyo, Japan).</p><p><strong>Patients and methods: </strong>We retrospectively analyzed data from patients who had biliary tract cancer with hilar biliary obstruction and underwent MB. Outcome measures included the overall technical success rate, quality of specimens, impact of MB results on the treatment strategy, and adverse events (AEs), which were compared between the conventional (Conv) group and the ES group.</p><p><strong>Results: </strong>A total of 91 patients were included. The overall technical success rate was significantly higher in the ES group (92%, 43/47) than in the Conv group (59%, 26/44) ( <i>P</i> < 0.05). The rate of samples containing both biliary epithelium and stromal tissue was significantly higher in the ES group than in the Conv group (77% [67/87] vs. 47% [32/68]; <i>P</i> < 0.05). MB results affected the treatment strategy in one patient (2.3%) in the Conv group and five patients (11%) in the ES group ( <i>P</i> = 0.11). There was no significant difference between the two groups in terms of AEs.</p><p><strong>Conclusions: </strong>MB using ES significantly improved technical success and specimen quality, providing valuable information for preoperative assessment of patients with biliary tract cancer.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27871325"},"PeriodicalIF":2.3,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12908915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resection of large, broad-based pedunculated and semi-pedunculated colorectal polyps using a scissor-type endoscopic submucosal dissection knife. 使用剪刀型内镜下粘膜夹层刀切除大的、基础广泛的带蒂和半带蒂结肠息肉。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-29 eCollection Date: 2026-01-01 DOI: 10.1055/a-2788-3249
Robert Eckersley, Noriko Suzuki, Brian Saunders, Adam Humphries

Background and study aims: Endoscopic resection of large, broad-based pedunculated and semi-pedunculated polyps can be technically difficult. Conventional snare resection risks immediate bleeding and piecemeal excision. We evaluated the safety and efficacy of a scissor-type endoscopic submucosal dissection (ST-ESD) knife for these lesions.

Patients and methods: A single-center retrospective study was conducted of all patients who underwent ST-ESD resection of pedunculated or semi-pedunculated polyps with head size ≧ 20 mm and stalk width ≧ 10 mm. Primary outcomes were en bloc resection, intraprocedural and delayed bleeding, and perforation. Secondary outcomes were R0 resection and recurrence at first follow-up.

Results: Fifty-eight resections were identified (75.6% male; median age 60 years). Median head size was 30 mm (range 20-70) with median stalk width 15 mm (range 10-50). Of them, 74.1% were in the sigmoid colon. Successful resection was achieved in 52 of 58 (89.7%); 44 (75.9%) by ST-ESD alone and eight (13.8%) snare-assisted. Six (10.3%) were abandoned; five due to visible muscle retraction and one dense stalk fibrosis. All successful resections were en bloc with R0 in 52 of 52 (100%). Minor intraprocedural bleeding occurred in nine of 58 (15.5%) and was controlled endoscopically. Forty-seven of 52 defects (90.4%) were closed prophylactically with endoscopic clips. There were no incidences of delayed bleeding or perforation. Histopathology was benign in 51 of 52 (98.1%). One adenocarcinoma was treated surgically for high-risk features. Endoscopic follow-up was available in 41 of 52 (78.8%) with no recurrence seen. Zero of six abandoned cases referred for surgery contained evidence of malignancy in the surgical specimen.

Conclusions: ST-ESD is safe and effective for resection of large, broad-based pedunculated and semi-pedunculated colorectal polyps.

背景和研究目的:内镜下切除大的、基础广泛的带梗和半带梗息肉在技术上是困难的。传统的圈套切除有立即出血和分段切除的风险。我们评估了剪刀型内镜下粘膜下剥离(ST-ESD)刀治疗这些病变的安全性和有效性。患者和方法:对所有接受ST-ESD治疗的头部大小≧20mm、茎宽≧10mm带梗或半带梗息肉的患者进行单中心回顾性研究。主要结果为整块切除、术中出血和延迟性出血以及穿孔。次要结果为R0切除和第一次随访时复发。结果:58例切除(75.6%为男性,中位年龄60岁)。穗粗中值为30毫米(范围20-70),茎宽中值为15毫米(范围10-50)。其中74.1%位于乙状结肠。58例患者中有52例(89.7%)成功切除;单纯ST-ESD 44例(75.9%),诱捕辅助8例(13.8%)。放弃6例(10.3%);5个是明显的肌肉收缩1个是密集的茎纤维化。所有成功切除均为整体,52例(100%)中有52例R0。58例中有9例(15.5%)发生轻微术中出血,经内镜控制。52例缺损中47例(90.4%)采用内窥镜夹预防性封闭。没有迟发性出血或穿孔的发生。52例中51例(98.1%)为良性。一例腺癌因高危特征接受手术治疗。52例患者中有41例(78.8%)进行了内镜随访,未见复发。6例被遗弃的手术病例中,零例在手术标本中含有恶性肿瘤的证据。结论:ST-ESD是一种安全、有效的切除大面积带蒂和半带蒂结直肠息肉的方法。
{"title":"Resection of large, broad-based pedunculated and semi-pedunculated colorectal polyps using a scissor-type endoscopic submucosal dissection knife.","authors":"Robert Eckersley, Noriko Suzuki, Brian Saunders, Adam Humphries","doi":"10.1055/a-2788-3249","DOIUrl":"https://doi.org/10.1055/a-2788-3249","url":null,"abstract":"<p><strong>Background and study aims: </strong>Endoscopic resection of large, broad-based pedunculated and semi-pedunculated polyps can be technically difficult. Conventional snare resection risks immediate bleeding and piecemeal excision. We evaluated the safety and efficacy of a scissor-type endoscopic submucosal dissection (ST-ESD) knife for these lesions.</p><p><strong>Patients and methods: </strong>A single-center retrospective study was conducted of all patients who underwent ST-ESD resection of pedunculated or semi-pedunculated polyps with head size ≧ 20 mm and stalk width ≧ 10 mm. Primary outcomes were en bloc resection, intraprocedural and delayed bleeding, and perforation. Secondary outcomes were R0 resection and recurrence at first follow-up.</p><p><strong>Results: </strong>Fifty-eight resections were identified (75.6% male; median age 60 years). Median head size was 30 mm (range 20-70) with median stalk width 15 mm (range 10-50). Of them, 74.1% were in the sigmoid colon. Successful resection was achieved in 52 of 58 (89.7%); 44 (75.9%) by ST-ESD alone and eight (13.8%) snare-assisted. Six (10.3%) were abandoned; five due to visible muscle retraction and one dense stalk fibrosis. All successful resections were en bloc with R0 in 52 of 52 (100%). Minor intraprocedural bleeding occurred in nine of 58 (15.5%) and was controlled endoscopically. Forty-seven of 52 defects (90.4%) were closed prophylactically with endoscopic clips. There were no incidences of delayed bleeding or perforation. Histopathology was benign in 51 of 52 (98.1%). One adenocarcinoma was treated surgically for high-risk features. Endoscopic follow-up was available in 41 of 52 (78.8%) with no recurrence seen. Zero of six abandoned cases referred for surgery contained evidence of malignancy in the surgical specimen.</p><p><strong>Conclusions: </strong>ST-ESD is safe and effective for resection of large, broad-based pedunculated and semi-pedunculated colorectal polyps.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27883249"},"PeriodicalIF":2.3,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12908908/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Sah et al. 回复Sah等人。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-27 eCollection Date: 2026-01-01 DOI: 10.1055/a-2777-8310
Hiroki Fukuya, Eikichi Ihara, Yoichiro Iboshi, Yorinobu Sumida, Daisuke Yoshimura, Shohei Hamada, Taisuke Sasaki, Akito Ohkubo, Shuichi Itonaga, Hitoshi Homma, Ryota Okitsu, Akihisa Ohno, Mitsuru Esaki, Naohiko Harada
{"title":"Reply to Sah et al.","authors":"Hiroki Fukuya, Eikichi Ihara, Yoichiro Iboshi, Yorinobu Sumida, Daisuke Yoshimura, Shohei Hamada, Taisuke Sasaki, Akito Ohkubo, Shuichi Itonaga, Hitoshi Homma, Ryota Okitsu, Akihisa Ohno, Mitsuru Esaki, Naohiko Harada","doi":"10.1055/a-2777-8310","DOIUrl":"https://doi.org/10.1055/a-2777-8310","url":null,"abstract":"","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27778310"},"PeriodicalIF":2.3,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12908911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel over-the-scope endoscopic assisting platform for expanding therapeutic capabilities: Preclinical feasibility study (with video). 扩大治疗能力的新型超镜内窥镜辅助平台:临床前可行性研究(含视频)。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-27 eCollection Date: 2026-01-01 DOI: 10.1055/a-2781-5768
Jie Xia, Muhan Li, Feifei Wang, Xincong Xi, Yueqin Qian, Xinjian Wan

The limitations of single-channel endoscopy in complex gastrointestinal disease prompted design of the over-the-scope endoscopic assisting platform (OTS-EAP), a low-profile cap that converts any diagnostic endoscope into a dual-channel therapeutic system. Ex-vivo bending tests and in-vivo porcine studies evaluated safety and feasibility for three tasks: 1) high-flow irrigation and suction of clot/chyme; 2) radiation-free, direct-visual stent delivery; and 3) purse-string closure of large endoscopic submucosal dissection defects. OTS-EAP preserved endoscope flexibility and torque; rapid valve-switching cleared the field within seconds, stents were deployed precisely under endoscopic view, and dual-instrument coordination simplified defect closure. The platform offers an inexpensive, radiation-sparing "third hand" for emergencies, bleeding, stenting, and suturing, warranting clinical translation.

单通道内窥镜在复杂胃肠道疾病中的局限性促使了超镜内窥镜辅助平台(OTS-EAP)的设计,这是一种将任何诊断内窥镜转换为双通道治疗系统的低形状帽。离体弯曲试验和猪体内研究评估了三个任务的安全性和可行性:1)高流量冲洗和吸血/食糜;2)无辐射、直接目视的支架置入;3)内镜下粘膜下夹层大缺损的荷包缝合。OTS-EAP保留了内窥镜的灵活性和扭矩;快速阀门切换在几秒钟内清除了区域,在内镜下精确部署支架,双仪器协调简化了缺陷闭合。该平台为紧急情况、出血、支架植入和缝合提供了廉价、节省辐射的“第三只手”,保证了临床翻译。
{"title":"A novel over-the-scope endoscopic assisting platform for expanding therapeutic capabilities: Preclinical feasibility study (with video).","authors":"Jie Xia, Muhan Li, Feifei Wang, Xincong Xi, Yueqin Qian, Xinjian Wan","doi":"10.1055/a-2781-5768","DOIUrl":"https://doi.org/10.1055/a-2781-5768","url":null,"abstract":"<p><p>The limitations of single-channel endoscopy in complex gastrointestinal disease prompted design of the over-the-scope endoscopic assisting platform (OTS-EAP), a low-profile cap that converts any diagnostic endoscope into a dual-channel therapeutic system. Ex-vivo bending tests and in-vivo porcine studies evaluated safety and feasibility for three tasks: 1) high-flow irrigation and suction of clot/chyme; 2) radiation-free, direct-visual stent delivery; and 3) purse-string closure of large endoscopic submucosal dissection defects. OTS-EAP preserved endoscope flexibility and torque; rapid valve-switching cleared the field within seconds, stents were deployed precisely under endoscopic view, and dual-instrument coordination simplified defect closure. The platform offers an inexpensive, radiation-sparing \"third hand\" for emergencies, bleeding, stenting, and suturing, warranting clinical translation.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"14 ","pages":"a27815768"},"PeriodicalIF":2.3,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12908909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endoscopy International Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1